1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > West Nile Virus Infections Global Clinical Trials Review, H2, 2014

West Nile Virus Infections Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “West Nile Virus Infections Global Clinical Trials Review, H2, 2014" provides data on the West Nile Virus Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on West Nile Virus Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating West Nile Virus Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

West Nile Virus Infections Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 4
West Nile Virus Infections 4
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in North America 8
Clinical Trials by G7 Countries: Proportion of West Nile Virus Infections to Infectious Disease Clinical Trials 9
Clinical Trials by Phase in G7 Countries 10
Clinical Trials in G7 Countries by Trial Status 11
Clinical Trials by Phase 12
Clinical Trials by Trial Status 13
Clinical Trials by End Point Status 14
Unaccomplished Trials of West Nile Virus Infections 15
Subjects Recruited Over a Period of Time 16
Clinical Trials by Sponsor Type 17
Prominent Sponsors 18
Top Companies Participating in West Nile Virus Infections Therapeutics Clinical Trials 19
Prominent Drugs 20
Clinical Trial Profiles 21
Clinical Trial Overview of Top Companies 21
MacroGenics, Inc. 21
Clinical Trial Overview of MacroGenics, Inc. 21
Sarepta Therapeutics, Inc. 22
Clinical Trial Overview of Sarepta Therapeutics, Inc. 22
Sanofi 23
Clinical Trial Overview of Sanofi 23
Acuvax Ltd 24
Clinical Trial Overview of Acuvax Ltd 24
Clinical Trial Overview of Top Institutes / Government 25
The National Institute of Allergy and Infectious Diseases 25
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 25
National Institutes of Health Clinical Center 26
Clinical Trial Overview of National Institutes of Health Clinical Center 26
Five Key Clinical Profiles 27
Appendix 55
Abbreviations 55
Definitions 55
Research Methodology 56
Secondary Research 56
About GlobalData 57
Contact Us 57
Disclaimer 57
Source 57

List of Tables

West Nile Virus Infections Therapeutics, Global, Clinical Trials by Region, 2014* 5
West Nile Virus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 6
West Nile Virus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 7
West Nile Virus Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 8
Proportion of West Nile Virus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 9
West Nile Virus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 10
West Nile Virus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 11
West Nile Virus Infections Therapeutics, Global, Clinical Trials by Phase, 2014* 12
West Nile Virus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 13
West Nile Virus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 14
West Nile Virus Infections Therapeutics, Global, Terminated Clinical Trials, 2014* 15
West Nile Virus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 16
West Nile Virus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 17
West Nile Virus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 18
West Nile Virus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 19
West Nile Virus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 20
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by MacroGenics, Inc., 2014* 21
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarepta Therapeutics, Inc., 2014* 22
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 23
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Acuvax Ltd, 2014* 24
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 25
West Nile Virus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014* 26

List of Figures

West Nile Virus Infections Therapeutics, Global, Clinical Trials by Region (%), 2014* 5
West Nile Virus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 6
West Nile Virus Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 8
Proportion of West Nile Virus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 9
West Nile Virus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 10
West Nile Virus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 11
West Nile Virus Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014* 12
West Nile Virus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 13
West Nile Virus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 14
West Nile Virus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 16
West Nile Virus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 17
West Nile Virus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 18
West Nile Virus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 19
GlobalData Methodology 56

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.